MYC and breast cancer: Accordingly, the upregulation of β-catenin in RUNX1-depleted ER+ breast cancer cell lines was not associated with increased expression of the LEF/TCF-responsive G1/S regulatory genes CCND1 and c-Myc (Fig. 6c; Supplementary Fig. 5).